MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
38.05
+1.70 (4.68%)
At close: Apr 2, 2025, 4:00 PM
37.00
-1.05 (-2.76%)
After-hours: Apr 2, 2025, 7:33 PM EDT

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,4083,4153,620409-
Market Cap Growth
-5.66%-5.66%784.47%--
Enterprise Value
1,9622,9323,189353-
Last Close Price
36.3554.1560.3910.509.89
PB Ratio
5.137.537.055.95-
P/TBV Ratio
7.647.647.308.37-
Debt / Equity Ratio
0.010.010.010.00-1.29
Quick Ratio
20.0720.0751.389.440.39
Current Ratio
21.1121.1151.599.980.46
Return on Equity (ROE)
-25.08%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-17.81%-17.81%-11.21%-93.99%-
Return on Capital (ROIC)
-18.38%-18.38%-11.54%-112.32%-
Earnings Yield
-4.94%-3.48%-1.00%-12.21%-
FCF Yield
-4.87%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-27.99%-27.99%-67.30%-274.47%-
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q